This blog posting represents the views of the author, David Fosberry. Those opinions may change over time. They do not constitute an expert legal or financial opinion.
If you have comments on this blog posting, please email me .
The Opinion Blog is organised by threads, so each post is identified by a thread number ("Major" index) and a post number ("Minor" index). If you want to view the index of blogs, click here to download it as an Excel spreadsheet.
Click here to see the whole Opinion Blog.
To view, save, share or refer to a particular blog post, use the link in that post (below/right, where it says "Show only this post").
Posted on 6th June 2021
|Show only this post|
Show all posts in this thread (Covid-19).
This report on the BBC is one of a whole series of articles about the number of cases of black fungus (mucormycosis) in patients recovering from Covid-19. This seems to be especially problematic in India.
Initially, suspicion fell on treatment with steroids (now a standard medication used in severe cases of the coronavirus), but now the spotlight is on diabetes. In India, amongst patients recovering from Covid-19 94% of those who had the fungal infection also suffered from diabetes.
The IDF (International Diabetes Federation) estimates that about 57% of those with diabetes in India, Nepal, Bangladesh, Sri Lanka are undiagnosed, and nearly all of these are found in India.
We should, however, be cautious in interpreting these statistic. Covid-19 is now known to trigger diabetes (something which the author of the BBC article seems unaware of), so the number of cases of black fungus amongst diabetics recovering from Covid-19 will inevitably be distorted by cases of diabetes brought on by the coronavirus.